Oncology Corporate Profile
GenSpera, Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|mipsagargin / G-202||PSA activated prodrug||Glioblastoma Multiforme (GBM)||II|
|mipsagargin / G-202||PSA activated prodrug||Hepatocellular carcinoma (HCC)||II|
|mipsagargin / G-202||PSA activated prodrug||Prostate cancer||I|
|G-115||PSA activated prodrug||Prostate cancer||Preclinical|
View additional information on product candidates here »